Unicyte’s Unique Stem Cell Approach Could Cure Children With Rare Disorder
Executive Summary
Emerging Company Profile: Swiss biotech Unicyte is using donor-derived liver stem cells across a range of therapeutic areas, with its lead asset showing curative potential in urea cycle disorders.